OncLive’s Post

View organization page for OncLive, graphic

29,677 followers

Hear James McCloskey, MD, of John Theurer Cancer Center at Hackensack University Medical Center and Thomas LeBlanc, MD, MA, of Duke Health discuss how risk stratification tools like IPSS-M are applied in practice for lower-risk myelodysplastic syndromes, addressing prognosis communication and current treatment challenges for this patient group. Watch more here: https://lnkd.in/gP97tcAi

To view or add a comment, sign in

Explore topics